Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of methotrexate with or without
cyclophosphamide in treating patients who have lymphocytic leukemia with neutropenia or
anemia.